These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18285834)

  • 1. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
    Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
    Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallmann syndrome.
    Dodé C; Hardelin JP
    Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
    Sinisi AA; Asci R; Bellastella G; Maione L; Esposito D; Elefante A; De Bellis A; Bellastella A; Iolascon A
    Hum Reprod; 2008 Oct; 23(10):2380-4. PubMed ID: 18596028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Zhang C; Pignatelli D; Li JD; Raivio T; Cole LW; Plummer L; Jacobson-Dickman EE; Mellon PL; Zhou QY; Crowley WF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17447-52. PubMed ID: 17959774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical genetics of Kallmann syndrome.
    Dodé C; Hardelin JP
    Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROK2/PROKR2 Signaling and Kallmann Syndrome.
    Dodé C; Rondard P
    Front Endocrinol (Lausanne); 2013; 4():19. PubMed ID: 23596439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
    Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
    Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel aminoterminal mutation in the KAL-1 gene in a large pedigree with X-linked Kallmann syndrome.
    Gu WX; Colquhoun-Kerr JS; Kopp P; Bode HH; Jameson JL
    Mol Genet Metab; 1998 Sep; 65(1):59-61. PubMed ID: 9787096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
    Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
    Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).
    Zenaty D; Bretones P; Lambe C; Guemas I; David M; Léger J; de Roux N
    Mol Cell Endocrinol; 2006 Jul; 254-255():78-83. PubMed ID: 16757108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
    McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.